Celltrion

Celltrion Healthcare Presents Clinical Data Showing That Inflammatory Bowel Disease Patients Should Be Treated With Biosimilar Monoclonal Antibody (mAb) Infliximab

IBD News, News
Documented clinical experience was recently presented by Celltrion Healthcare’s satellite symposium during the 2014 United European Gastroenterology (UEGW) showing evidence that patients with inflammatory bowel disease (IBD) — Crohn’s disease and ulcerative colitis — should be treated with the biosimilar monoclonal antibody ... Read more